#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Demyelination Mitochondrial encephalomyopathy Osteogenesis imperfecta Osteosarcoma Oesophageal squamous cell carcinoma stage II Antiphospholipid syndrome White matter lesion Iron overload PIK3CA related overgrowth spectrum Langerhans cell sarcoma Erythema multiforme Infantile apnoea Pleomorphic liposarcoma Malignant fibrous histiocytoma Polyneuropathy More trials…

    Learn about Rare Diseases

    Rhabdomyosarcoma – Treatment Pelizaeus-Merzbacher disease – Diagnostics Choroid melanoma – Treatment Rhabdomyosarcoma – Trials in Disease Idiopathic pulmonary fibrosis – Trials in Disease Mantle cell lymphoma refractory – Treatment Osteosarcoma metastatic Isodicentric chromosome 15 syndrome – Trials in Disease Toxic epidermal necrolysis Langerhans’ cell histiocytosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bgb-15025 Citrate Jk06 SODIUM IBANDRONATE Ivacaftor Naproxen Sodium Istaroxime Istradefylline AP31969 SULFATE Isotretinoin Stro-002 Minoxidil Vgl101 Pyridoxine Hydrochloride ARI0008 Rilpivirine Hydrochloride VENT-03 Pivekimab Sunirine Anthoxanthum Odoratum ZIGAKIBART 68Ganota-Anti-Her2 Vhh1 More therapies…

    Learn about Your Condition

    Hypomagnesaemia Breast cancer stage IV Round cell liposarcoma Endocarditis enterococcal Spinal osteoarthritis Oxygen therapy Lumbosacral radiculopathy Viral myocarditis Encephalitis autoimmune Testicular germ cell cancer Arrhythmia supraventricular Renal cancer Hepatic neoplasm Perineal injury Juvenile idiopathic arthritis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Biliary neoplasm

  • Study of MP0317 with durvalumab, gemcitabine and cisplatin combination therapy as first-line treatment for patients with advanced biliary tract cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Biliary neoplasm
    Investigated Drugs:
    • Cisplatin
    • Durvalumab
    • Gemcitabine
    France

  • Study on Ifinatamab Deruxtecan for Patients with Recurrent or Metastatic Solid Tumors

    Recruiting

    1 1 1
    Investigated Diseases:
    • Biliary neoplasm
    • Malignant melanoma
    • Endometrial cancer
    Investigated Drugs:
    • Ifinatamab Deruxtecan
    Belgium France Germany Ireland Italy The Netherlands +3

  • Study on AZD0901 and Drug Combination for Patients with Advanced Gastric, Gastroesophageal, and Pancreatic Cancers Expressing Claudin 18.2

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Biliary neoplasm
    • Gastric cancer
    • Oesophageal carcinoma
    Investigated Drugs:
    • Azd0901
    • Irinotecan
    • Fluorouracil
    Poland Spain

  • Study on the Safety and Effectiveness of MK-2870 Alone or with Other Drugs for Patients with Colorectal, Pancreatic, and Biliary Tract Cancers

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Biliary neoplasm
    • Ductal adenocarcinoma of pancreas
    • Colorectal cancer
    Investigated Drugs:
    • H2-Receptor Antagonists
    • Sacituzumab Tirumotecan
    • Calcium Folinate
    Italy Spain

  • Study on Maintenance Therapy with Cisplatin, Durvalumab, and Trastuzumab for Patients with Advanced Biliary Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Biliary neoplasm
    Investigated Drugs:
    • Futibatinib
    • Neratinib
    • Ivosidenib
    Belgium France

  • Study on Cisplatin, Gemcitabine, and Paclitaxel Albumin-Bound for Patients with Resectable Biliary Tract Cancer at High Risk of Recurrence

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Biliary neoplasm
    Investigated Drugs:
    • Capecitabine
    • Cisplatin
    • Gemcitabine Hydrochloride
    Italy
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!